Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 297

1.

Prognostic characteristics and body mass index in patients with pulmonary embolism: does size matter?

Beenen LFM, Scheres LJJ, Stoker J, Middeldorp S.

ERJ Open Res. 2020 Jan 10;6(1). pii: 00163-2019. doi: 10.1183/23120541.00163-2019. eCollection 2020 Jan.

PMID:
31956657
2.

Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism.

Scheres LJJ, Lijfering WM, Groenewegen NFM, Koole S, de Groot CJM, Middeldorp S, Cannegieter SC.

Hypertension. 2020 Jan 13:HYPERTENSIONAHA11914280. doi: 10.1161/HYPERTENSIONAHA.119.14280. [Epub ahead of print]

PMID:
31928113
3.

An anticoagulant that does not cause bleeding - an abrupt stop on the road to the Holy Grail.

Meijers JCM, Middeldorp S.

J Thromb Haemost. 2019 Dec;17(12):2019-2021. doi: 10.1111/jth.14638. No abstract available.

4.

The risk of cesarean delivery after labor induction among women with prior pregnancy complications: a subgroup analysis of the AFFIRM study.

Skeith L, Le Gal G, de Vries JIP, Middeldorp S, Goddijn M, Kaaja R, Gris JC, Martinelli I, Schleußner E, Petroff D, Langlois N, Rodger MA; AFFIRM investigators.

BMC Pregnancy Childbirth. 2019 Nov 29;19(1):455. doi: 10.1186/s12884-019-2615-x.

5.

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.

Mulder FI, van Es N, Kraaijpoel N, Di Nisio M, Carrier M, Duggal A, Gaddh M, Garcia D, Grosso MA, Kakkar AK, Mercuri MF, Middeldorp S, Royle G, Segers A, Shivakumar S, Verhamme P, Wang T, Weitz JI, Zhang G, Büller HR, Raskob G.

Thromb Res. 2020 Jan;185:13-19. doi: 10.1016/j.thromres.2019.11.007. Epub 2019 Nov 9.

PMID:
31733403
6.

Clinical implications of incidental venous thromboembolism in cancer patients.

Mulder FI, Di Nisio M, Ay C, Carrier M, Bosch FTM, Segers A, Kraaijpoel N, Grosso MA, Zhang G, Verhamme P, Wang TF, Weitz JI, Middeldorp S, Raskob G, Beenen LFM, Büller HR, van Es N.

Eur Respir J. 2019 Nov 14. pii: 1901697. doi: 10.1183/13993003.01697-2019. [Epub ahead of print]

PMID:
31727694
7.

Development of a Plasma-Based Assay to Measure the Susceptibility of Factor V to Inhibition by the C-Terminus of TFPIα.

van Doorn P, Rosing J, Campello E, Middeldorp S, Simioni P, Meijers JCM, Hackeng TM, Castoldi E.

Thromb Haemost. 2020 Jan;120(1):55-64. doi: 10.1055/s-0039-1700516. Epub 2019 Nov 8.

PMID:
31705518
8.

Thrombosis and hemostasis health in pregnancy: Registries from the International Society on Thrombosis and Haemostasis.

Othman M, Santamaría Ortiz A, Cerdá M, Erez O, Minford A, Obeng-Tuudah D, Blondon M, Bistervels I, Middeldorp S, Abdul-Kadir R.

Res Pract Thromb Haemost. 2019 Aug 1;3(4):607-614. doi: 10.1002/rth2.12243. eCollection 2019 Oct.

9.

Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database.

Barco S, Mahmoudpour SH, Valerio L, Klok FA, Münzel T, Middeldorp S, Ageno W, Cohen AT, Hunt BJ, Konstantinides SV.

Lancet Respir Med. 2019 Oct 11. pii: S2213-2600(19)30354-6. doi: 10.1016/S2213-2600(19)30354-6. [Epub ahead of print]

PMID:
31615719
10.

Transgender patients and the role of the coagulation clinician.

Connors JM, Middeldorp S.

J Thromb Haemost. 2019 Nov;17(11):1790-1797. doi: 10.1111/jth.14626. Epub 2019 Sep 13. Review.

PMID:
31465627
11.

Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC.

Tardy B, Chalayer E, Kamphuisen PW, Ni Ainle F, Verhamme P, Varlet MN, Chauleur C, Rodger M, Merah A, Buchmuller A, Bistervels I, De Sancho MT, Middeldorp S, Bertoletti L; SSC Subcommittee on Control of Anticoagulation of the ISTH.

J Thromb Haemost. 2019 Nov;17(11):1979-1988. doi: 10.1111/jth.14576. Epub 2019 Aug 12. No abstract available.

PMID:
31402557
12.

Thromboprophylaxis in pregnant women: For whom and which LMWH dosage?

Tardy B, Buchmuller A, Bistervels IM, Ni Ainle F, Middeldorp S.

J Thromb Haemost. 2019 Aug;17(8):1401-1403. doi: 10.1111/jth.14547. No abstract available.

PMID:
31368223
13.

Sex matters: Practice 5P's when treating young women with venous thromboembolism.

Bistervels IM, Scheres LJJ, Hamulyák EN, Middeldorp S.

J Thromb Haemost. 2019 Sep;17(9):1417-1429. doi: 10.1111/jth.14549. Epub 2019 Jul 23. Review.

14.

Fever and a rapidly progressive skin ulcer after a visit to Morocco: A diagnostic challenge.

Anas AA, Prins JM, Bode N, de Vries HJC, Middeldorp S, Grobusch MP.

Travel Med Infect Dis. 2019 Sep - Oct;31:101429. doi: 10.1016/j.tmaid.2019.05.015. Epub 2019 May 31. No abstract available.

PMID:
31158504
15.

Creatine kinase is associated with blood pressure during pregnancy.

Horjus DL, Bokslag A, Hutten BA, van den Born BH, Middeldorp S, Vrijkotte TGM.

J Hypertens. 2019 Jul;37(7):1467-1474. doi: 10.1097/HJH.0000000000001900.

PMID:
31145714
16.

Endogenous sex hormones and risk of venous thromboembolism in young women.

Scheres LJJ, van Hylckama Vlieg A, Ballieux BEPB, Fauser BCJM, Rosendaal FR, Middeldorp S, Cannegieter SC; CREW consortium.

J Thromb Haemost. 2019 Aug;17(8):1297-1304. doi: 10.1111/jth.14474. Epub 2019 Jun 4.

17.

Diagnosing and treating antiphospholipid syndrome: a consensus paper.

Limper M, de Leeuw K, Lely AT, Westerink J, Teng YKO, Eikenboom J, Otter S, Jansen AJG, V D Ree M, Spierings J, Kruyt ND, van der Molen R, Middeldorp S, Leebeek FWG, Bijl M, Urbanus RT.

Neth J Med. 2019 Apr;77(3):98-108.

18.

Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis.

Klaassen ILM, Lauw MN, Fiocco M, van der Sluis IM, Pieters R, Middeldorp S, van de Wetering MD, de Groot-Kruseman HA, van Ommen CH.

Res Pract Thromb Haemost. 2019 Feb 27;3(2):234-241. doi: 10.1002/rth2.12182. eCollection 2019 Apr.

19.

Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study.

Ende-Verhaar YM, Meijboom LJ, Kroft LJM, Beenen LFM, Boon GJAM, Middeldorp S, Nossent EJ, Symersky P, Huisman MV, Bogaard HJ, Vonk Noordegraaf A, Klok FA.

J Heart Lung Transplant. 2019 Jul;38(7):731-738. doi: 10.1016/j.healun.2019.03.003. Epub 2019 Mar 15.

PMID:
30962147
20.

Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism.

van der Pol LM, Tromeur C, Bistervels IM, Ni Ainle F, van Bemmel T, Bertoletti L, Couturaud F, van Dooren YPA, Elias A, Faber LM, Hofstee HMA, van der Hulle T, Kruip MJHA, Maignan M, Mairuhu ATA, Middeldorp S, Nijkeuter M, Roy PM, Sanchez O, Schmidt J, Ten Wolde M, Klok FA, Huisman MV; Artemis Study Investigators.

N Engl J Med. 2019 Mar 21;380(12):1139-1149. doi: 10.1056/NEJMoa1813865.

PMID:
30893534
21.

Creatine kinase and blood pressure in women with a history of early-onset preeclampsia.

Horjus DL, Bokslag A, Hooijberg F, Hutten BA, Middeldorp S, de Groot CJM.

Pregnancy Hypertens. 2019 Jan;15:118-122. doi: 10.1016/j.preghy.2018.12.009. Epub 2018 Dec 31.

PMID:
30825907
22.

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.

Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, Yue P, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Demchuk AM, Pallin DJ, Concha M, Goodman S, Leeds J, Souza S, Siegal DM, Zotova E, Meeks B, Ahmad S, Nakamya J, Milling TJ Jr; ANNEXA-4 Investigators.

N Engl J Med. 2019 Apr 4;380(14):1326-1335. doi: 10.1056/NEJMoa1814051. Epub 2019 Feb 7.

23.

Postpartum Period Is a Risk Factor for Cerebral Venous Thrombosis.

Silvis SM, Lindgren E, Hiltunen S, Devasagayam S, Scheres LJ, Jood K, Zuurbier SM, Kleinig TJ, Silver FL, Mandell DM, Middeldorp S, Putaala J, Cannegieter SC, Tatlisumak T, Coutinho JM.

Stroke. 2019 Feb;50(2):501-503. doi: 10.1161/STROKEAHA.118.023017.

PMID:
30621526
24.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.

Bates SM, Rajasekhar A, Middeldorp S, McLintock C, Rodger MA, James AH, Vazquez SR, Greer IA, Riva JJ, Bhatt M, Schwab N, Barrett D, LaHaye A, Rochwerg B.

Blood Adv. 2018 Nov 27;2(22):3317-3359. doi: 10.1182/bloodadvances.2018024802.

25.

Sex-specific differences in the distal versus proximal presenting location of acute deep vein thrombosis.

Trinchero A, Scheres LJJ, Prochaska JH, Ambaglio C, Wild PS, Middeldorp S, Konstantinides SV, Barco S.

Thromb Res. 2018 Dec;172:74-79. doi: 10.1016/j.thromres.2018.10.025. Epub 2018 Oct 26.

PMID:
30384038
26.

Treatment of Lower Extremity Superficial Thrombophlebitis.

Di Nisio M, Wichers I, Middeldorp S.

JAMA. 2018 Dec 11;320(22):2367-2368. doi: 10.1001/jama.2018.16623.

PMID:
30383173
27.

Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials.

Scheres LJJ, Lijfering WM, Middeldorp S, Cheung YW, Barco S, Cannegieter SC, Coppens M.

Res Pract Thromb Haemost. 2018 Aug 18;2(4):689-695. doi: 10.1002/rth2.12142. eCollection 2018 Oct.

28.

Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis.

Amin EE, Ten Cate-Hoek AJ, Bouman AC, Meijer K, Tick L, Middeldorp S, Mostard G, Ten Wolde M, van den Heiligenberg S, van Wissen S, van de Poel M, Villalta S, Serné E, Otten HM, Klappe E, Prandoni P, Prins MH, Ten Cate H, Joore MA.

Lancet Haematol. 2018 Nov;5(11):e512-e519. doi: 10.1016/S2352-3026(18)30151-0. Epub 2018 Oct 9.

PMID:
30314712
29.

Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis.

Amin EE, Bistervels IM, Meijer K, Tick LW, Middeldorp S, Mostard G, van de Poel M, Serné EH, Otten HM, Klappe EM, Joore MA, Ten Cate H, Ten Wolde M, Ten Cate-Hoek AJ.

Blood. 2018 Nov 22;132(21):2298-2304. doi: 10.1182/blood-2018-03-836783. Epub 2018 Sep 20.

30.

Lower prevalence of subsegmental pulmonary embolism after application of the YEARS diagnostic algorithm.

van der Pol LM, Bistervels IM, van Mens TE, van der Hulle T, Beenen LFM, den Exter PL, Kroft LJM, Mairuhu ATA, Middeldorp S, van Werkhoven JM, Ten Wolde M, Huisman MV, Klok FA.

Br J Haematol. 2018 Nov;183(4):629-635. doi: 10.1111/bjh.15556. Epub 2018 Sep 10.

31.

Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists.

Bleker SM, Brekelmans MPA, Eerenberg ES, Cohen AT, Middeldorp S, Raskob G, Büller HR.

Thromb Haemost. 2017 Oct;117(10):1944-1951. doi: 10.1160/TH16-12-0946. Epub 2017 Nov 28.

PMID:
30151820
32.

The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.

Ten Cate H, Lensing AWA, Weitz JI, Middeldorp S, Beyer-Westendorf J, Kubitza D, Brighton T, Raskob GE, Mismetti P, Prandoni P, Gebel M, Prins MH.

Thromb Res. 2018 Oct;170:75-83. doi: 10.1016/j.thromres.2018.08.008. Epub 2018 Aug 15.

PMID:
30121419
33.

Everything the clinician needs to know about evidence-based anticoagulation in pregnancy.

Scheres LJJ, Bistervels IM, Middeldorp S.

Blood Rev. 2019 Jan;33:82-97. doi: 10.1016/j.blre.2018.08.001. Epub 2018 Aug 6. Review.

PMID:
30107951
34.

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.

Kraaijpoel N, Di Nisio M, Mulder FI, van Es N, Beyer-Westendorf J, Carrier M, Garcia D, Grosso M, Kakkar AK, Mercuri MF, Middeldorp S, Hernandez CR, Santamaria A, Schwocho L, Segers A, Verhamme P, Wang TF, Weitz JI, Zhang G, Zwicker JI, Büller HR, Raskob GE.

Thromb Haemost. 2018 Aug;118(8):1439-1449. doi: 10.1055/s-0038-1667001. Epub 2018 Jul 30.

PMID:
30060256
35.

Clinical outcome of patients with a vitamin K antagonist-associated bleeding treated with prothrombin complex concentrate.

Brekelmans MPA, Abdoellakhan RA, Scheres LJJ, Biedermann JS, Hutten BA, Meijer K, Cate HT, Huisman MV, Kruip MJHA, Middeldorp S, Coppens M.

Res Pract Thromb Haemost. 2017 Nov 13;2(1):77-84. doi: 10.1002/rth2.12055. eCollection 2018 Jan.

36.

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study.

Scheres L, Brekelmans M, Ageno W, Ay C, Büller HR, Eichinger S, Hutten BA, Klok FA, Middeldorp S, Schreiber K, Stach K, Blondon M, Delluc A.

BJOG. 2018 Nov;125(12):1581-1589. doi: 10.1111/1471-0528.15388. Epub 2018 Jul 20.

37.

Venous thromboembolism after induced abortion: the shorter the pregnancy, the lower the risk?

Middeldorp S, Ankum WM.

Lancet Haematol. 2018 Jul;5(7):e271-e272. doi: 10.1016/S2352-3026(18)30089-9. Epub 2018 Jun 8. No abstract available.

PMID:
29891178
38.

Clinical and economic impact of compression in the acute phase of deep vein thrombosis.

Amin EE, Joore MA, Ten Cate H, Meijer K, Tick LW, Middeldorp S, Mostard GJM, Ten Wolde M, van den Heiligenberg SM, van Wissen S, van de Poel MHW, Villalta S, Serné EH, Otten HM, Klappe EH, Prandoni P, Ten Cate-Hoek AJ.

J Thromb Haemost. 2018 Jun 1. doi: 10.1111/jth.14163. [Epub ahead of print]

PMID:
29856509
39.

Prognostic value of cardiovascular parameters in computed tomography pulmonary angiography in patients with acute pulmonary embolism.

Beenen LFM, Bossuyt PMM, Stoker J, Middeldorp S.

Eur Respir J. 2018 Jul 4;52(1). pii: 1702611. doi: 10.1183/13993003.02611-2017. Print 2018 Jul.

40.

ESHRE guideline: recurrent pregnancy loss.

ESHRE Guideline Group on RPL, Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S, Middeldorp S, Nelen W, Peramo B, Quenby S, Vermeulen N, Goddijn M.

Hum Reprod Open. 2018 Apr 6;2018(2):hoy004. doi: 10.1093/hropen/hoy004. eCollection 2018.

41.

Treatment for superficial thrombophlebitis of the leg.

Di Nisio M, Wichers IM, Middeldorp S.

Cochrane Database Syst Rev. 2018 Feb 25;2:CD004982. doi: 10.1002/14651858.CD004982.pub6. Review.

PMID:
29478266
42.

Sex-specific performance of pre-imaging diagnostic algorithms for pulmonary embolism.

van Mens TE, van der Pol LM, van Es N, Bistervels IM, Mairuhu ATA, van der Hulle T, Klok FA, Huisman MV, Middeldorp S.

J Thromb Haemost. 2018 May;16(5):858-865. doi: 10.1111/jth.13984. Epub 2018 Mar 22.

PMID:
29460484
43.

Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism.

Rodger M, Langlois N, Middeldorp S, Kahn S, Sandset PM, Brighton T, Huisman MV, Meyer G, Konstantinides S, Ageno W, Morange P, Garcia D, Kreuziger LB, Young L, Key N, Monreal M, Jiménez D.

Thromb Res. 2018 Mar;163:128-131. doi: 10.1016/j.thromres.2018.01.050. Epub 2018 Jan 31.

PMID:
29407624
44.

Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients.

Kraaijpoel N, van Es N, Bleker SM, Brekelmans MPA, Eerenberg ES, Middeldorp S, Cohen AT, Raskob GE, Büller HR.

Thromb Haemost. 2018 Jan;118(1):174-181. doi: 10.1160/TH17-04-0274. Epub 2018 Jan 5.

PMID:
29304537
45.

Genes associated with venous thromboembolism in colorectal cancer patients.

Ünlü B, van Es N, Arindrarto W, Kiełbasa SM, Mei H, Westerga J, Middeldorp S, Kuppen PJK, Otten JMMB, Cannegieter S, Versteeg HH.

J Thromb Haemost. 2018 Feb;16(2):293-302. doi: 10.1111/jth.13926. Epub 2018 Jan 15.

PMID:
29247594
46.

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.

Squizzato A, Bellesini M, Takeda A, Middeldorp S, Donadini MP.

Cochrane Database Syst Rev. 2017 Dec 14;12:CD005158. doi: 10.1002/14651858.CD005158.pub4. Review.

47.

Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial.

Ten Cate-Hoek AJ, Amin EE, Bouman AC, Meijer K, Tick LW, Middeldorp S, Mostard GJM, Ten Wolde M, van den Heiligenberg SM, van Wissen S, van de Poel MH, Villalta S, Serné EH, Otten HM, Klappe EH, Bistervels IM, Lauw MN, Piersma-Wichers M, Prandoni P, Joore MA, Prins MH, Ten Cate H; IDEAL DVT investigators.

Lancet Haematol. 2018 Jan;5(1):e25-e33. doi: 10.1016/S2352-3026(17)30227-2. Epub 2017 Dec 5.

PMID:
29217387
48.

Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study.

Cheung YW, Barco S, Mathôt RAA, van den Dool EJ, Stroobants AK, Serlie MJ, Middeldorp S, Coppens M.

Thromb Res. 2017 Dec;160:76-82. doi: 10.1016/j.thromres.2017.10.025. Epub 2017 Nov 4.

PMID:
29127863
49.

Cancer and risk of cerebral venous thrombosis: a case-control study.

Silvis SM, Hiltunen S, Lindgren E, Jood K, Zuurbier SM, Middeldorp S, Putaala J, Cannegieter SC, Tatlisumak T, Coutinho JM.

J Thromb Haemost. 2018 Jan;16(1):90-95. doi: 10.1111/jth.13903. Epub 2017 Dec 1.

50.

Whole exome sequencing in thrombophilic pedigrees to identify genetic risk factors for venous thromboembolism.

Cunha MLR, Meijers JCM, Rosendaal FR, Vlieg AVH, Reitsma PH, Middeldorp S.

PLoS One. 2017 Nov 8;12(11):e0187699. doi: 10.1371/journal.pone.0187699. eCollection 2017.

Supplemental Content

Loading ...
Support Center